Drugs / CD34+ selected peripheral blood stem cell graft
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01370213 | Sep 2011 → Apr 2016 | acute myeloid leukemia, myelodysplastic syndrome | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ selected peripheral blood stem cell graft | “Single donor filgrastim mobilized CD34+ selected peripheral blood stem cell graft” NCT01370213 ↗ |